Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Roesch

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanomaSelma Ugurel, Felix Kiecker, Stefan Fröhling, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2016
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipientSaskia Herz, Thomas Höfer, Matina Papapanagiotou, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cell|May 19, 2010
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growthAlexander Roesch, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, et al.
Microbiology Spectrum|May 22, 2023
Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed TherapiesJan Kehrmann, Fiona Koch, Skrollan Zumdick, et al.
International Wound Journal|December 9, 2014
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in GermanyFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 9, 2020
Fatal swelling of the groin - Clear cell sarcoma: a rare but important differential diagnosis to malignant melanomaAnne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanomaSelma Ugurel, Felix Kiecker, Stefan Fröhling, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2016
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipientSaskia Herz, Thomas Höfer, Matina Papapanagiotou, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cell|May 19, 2010
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growthAlexander Roesch, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, et al.
Microbiology Spectrum|May 22, 2023
Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed TherapiesJan Kehrmann, Fiona Koch, Skrollan Zumdick, et al.
International Wound Journal|December 9, 2014
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in GermanyFinja Jockenhöfer, Harald Gollnick, Katharina Herberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 9, 2020
Fatal swelling of the groin - Clear cell sarcoma: a rare but important differential diagnosis to malignant melanomaAnne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Pageof 11